Coagulation & Hemostasis
Coagulation & Hemostasis(凝血 & 止血)
Coagulation & Hemostasis 相关产品(123)
- GC18837Carbocyclic Thromboxane A2CAS: 74034-56-3
A TXA 2 analog with vasoconstrictor and anti-platelet aggregation activity
- GC200955,7-Dihydroxy-4-methylcoumarinCAS: 2107-76-8
A synthetic coumarin with diverse biological activities
- GC403365-cis CarbaprostacyclinCAS: 69609-77-4纯度: >99.00%
A stable analog of PGI 2 that weakly inhibits platelet aggregation
- GC40552(R)-AcenocoumarolCAS: 66556-77-2纯度: >98.00%
Longer-lived enantiomer of the anticoagulant acenocoumarol
- GC40553(S)-AcenocoumarolCAS: 66556-78-3纯度: >98.00%
Shorter-lived enantiomer of the anticoagulant acenocoumarol
- GC405856α-Prostaglandin I1CAS: 62777-90-6纯度: >99.00%
A potent inhibitor of ADP-induced platelet aggregation
- GC40590ent-8-iso-15(S)-Prostaglandin F2αCAS: 214748-66-0纯度: >98.00%
A vasoconstrictor and inhibitor of platelet aggregation
- GC4074513,14-dehydro-15-cyclohexyl CarbaprostacyclinCAS: 145375-81-1纯度: >98.00%
A stable PGI 2 analog
- GC4110215-deoxy-δ12,14-Prostaglandin D2CAS: 85235-11-6纯度: >95.00%
A metabolite of PGD 2 and an agonist of DP 2
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GA20982 | Boc-D-Phe-Pro-OH | 38675-10-4 | - | |
A synthetic intermediate | ||||
| GC17816 | I-BOP | 128719-90-4 | >95.00% | |
Potent agonist of TP receptor-mediated platelet aggregation and vascular smooth muscle contraction | ||||
| GC18219 | 6-hydroxy Warfarin | 17834-02-5 | >98.00% | |
A phase I metabolite of (+)-warfarin | ||||
| GC18323 | Picotamide | 32828-81-2 | >98.00% | |
Picotamide是一种血小板聚集抑制剂，IC 50 值为0.76μM。 | ||||
| GC18637 | 11β-Prostaglandin F2α | 38432-87-0 | >98.00% | |
The primary PGD 2 metabolite | ||||
| GC18707 | Pimprinine | 13640-26-1 | - | |
An alkaloid with diverse biological activities | ||||
| GC18768 | Prostaglandin E1 ethyl ester | 35900-16-4 | - | |
An esterified form of PGE 1 | ||||
| GC18837 | Carbocyclic Thromboxane A2 | 74034-56-3 | - | |
A TXA 2 analog with vasoconstrictor and anti-platelet aggregation activity | ||||
| GC18999 | Prostaglandin D1 | 17968-82-0 | >98.00% | |
An inhibitor of platelet aggregation | ||||
| GC20095 | 5,7-Dihydroxy-4-methylcoumarin | 2107-76-8 | - | |
A synthetic coumarin with diverse biological activities | ||||
| GC40157 | PAR4 (1-6) amide (mouse) (trifluoroacetate salt) | - | >95.00% | |
A peptide agonist of PAR4 | ||||
| GC40159 | PAR1 (1-6) (mouse, rat) (trifluoroacetate salt) | - | >95.00% | |
A peptide agonist of PAR1 | ||||
| GC40336 | 5-cis Carbaprostacyclin | 69609-77-4 | >99.00% | |
A stable analog of PGI 2 that weakly inhibits platelet aggregation | ||||
| GC40529 | 7-hydroxy Warfarin | 17834-03-6 | - | |
A phase I metabolite of (-)-warfarin | ||||
| GC40552 | (R)-Acenocoumarol | 66556-77-2 | >98.00% | |
Longer-lived enantiomer of the anticoagulant acenocoumarol | ||||
| GC40553 | (S)-Acenocoumarol | 66556-78-3 | >98.00% | |
Shorter-lived enantiomer of the anticoagulant acenocoumarol | ||||
| GC40585 | 6α-Prostaglandin I1 | 62777-90-6 | >99.00% | |
A potent inhibitor of ADP-induced platelet aggregation | ||||
| GC40586 | 6β-Prostaglandin I1 | 62770-50-7 | >99.00% | |
A stable PGI 2 analog with reduced potency | ||||
| GC40590 | ent-8-iso-15(S)-Prostaglandin F2α | 214748-66-0 | >98.00% | |
A vasoconstrictor and inhibitor of platelet aggregation | ||||
| GC40610 | Prostaglandin D3 | 71902-47-1 | >98.00% | |
An inhibitor of platelet aggregation | ||||
| GC40745 | 13,14-dehydro-15-cyclohexyl Carbaprostacyclin | 145375-81-1 | >98.00% | |
A stable PGI 2 analog | ||||
| GC40973 | 16(R)-Iloprost | 74843-13-3 | >98.00% | |
An inhibitor of platelet aggregation | ||||
| GC40974 | 16(S)-Iloprost | 74843-14-4 | - | |
A potent inhibitor of platelet aggregation | ||||
| GC41102 | 15-deoxy-δ12,14-Prostaglandin D2 | 85235-11-6 | >95.00% | |
A metabolite of PGD 2 and an agonist of DP 2 | ||||